Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Results of a Health Education Message Intervention on HPV Knowledge and Receipt of Follow-up Care among Latinas Infected with High-risk Human Papillomavirus.

Sanderson M, Khabele D, Brown CL, Harbi K, Alexander LR, Coker AL, Fernandez ME, Brandt HM, Fadden MK, Hull PC.

J Health Care Poor Underserved. 2015 Nov;26(4):1440-55. doi: 10.1353/hpu.2015.0131.

2.

Pending studies at hospital discharge: a pre-post analysis of an electronic medical record tool to improve communication at hospital discharge.

Kantor MA, Evans KH, Shieh L.

J Gen Intern Med. 2015 Mar;30(3):312-8. doi: 10.1007/s11606-014-3064-x. Epub 2014 Nov 22.

3.

Challenges and Recommendations to Recruiting Women Who Do Not Adhere to Follow-Up Gynecological Care.

Wordlaw-Stinson L, Jones S, Little S, Fish L, Vidal A, Smith JS, Hoyo C, Moorman PG.

Open J Prev Med. 2014 Mar 20;4(3):123-128.

4.

Psychosocial barriers to follow-up adherence after an abnormal cervical cytology test result among low-income, inner-city women.

Hui SK, Miller SM, Wen KY, Fang Z, Li T, Buzaglo J, Hernandez E.

J Prim Care Community Health. 2014 Oct;5(4):234-41. doi: 10.1177/2150131914529307. Epub 2014 Apr 9.

5.

Tailored telephone counseling to improve adherence to follow-up regimens after an abnormal pap smear among minority, underserved women.

Miller SM, Hui SK, Wen KY, Scarpato J, Zhu F, Buzaglo J, Hernandez EE.

Patient Educ Couns. 2013 Dec;93(3):488-95. doi: 10.1016/j.pec.2013.08.008. Epub 2013 Aug 19.

6.

Intervention to improve follow-up for abnormal Papanicolaou tests: a randomized clinical trial.

Breitkopf CR, Dawson L, Grady JJ, Breitkopf DM, Nelson-Becker C, Snyder RR.

Health Psychol. 2014 Apr;33(4):307-16. doi: 10.1037/a0032722. Epub 2013 Jun 3.

7.

Patient barriers to follow-up care for breast and cervical cancer abnormalities.

Tejeda S, Darnell JS, Cho YI, Stolley MR, Markossian TW, Calhoun EA.

J Womens Health (Larchmt). 2013 Jun;22(6):507-17. doi: 10.1089/jwh.2012.3590. Epub 2013 May 14.

8.

The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women.

Percac-Lima S, Benner CS, Lui R, Aldrich LS, Oo SA, Regan N, Chabner BA.

J Womens Health (Larchmt). 2013 May;22(5):426-31. doi: 10.1089/jwh.2012.3900. Epub 2013 Apr 26.

9.

Cervical cancer screening, diagnosis and treatment interventions for racial and ethnic minorities: a systematic review.

Glick SB, Clarke AR, Blanchard A, Whitaker AK.

J Gen Intern Med. 2012 Aug;27(8):1016-32. doi: 10.1007/s11606-012-2052-2. Review.

10.

Interventions targeted at women to encourage the uptake of cervical screening.

Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG.

Cochrane Database Syst Rev. 2011 May 11;(5):CD002834. doi: 10.1002/14651858.CD002834.pub2. Review.

11.

How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case.

Chocont√°-Piraquive LA, Alvis-Guzman N, De la Hoz-Restrepo F.

BMC Health Serv Res. 2010 Sep 16;10:270. doi: 10.1186/1472-6963-10-270.

12.

Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy.

Percac-Lima S, Aldrich LS, Gamba GB, Bearse AM, Atlas SJ.

J Gen Intern Med. 2010 Nov;25(11):1198-204. doi: 10.1007/s11606-010-1450-6. Epub 2010 Jul 21.

13.

Effect of incentives on insecticide-treated bed net use in sub-Saharan Africa: a cluster randomized trial in Madagascar.

Krezanoski PJ, Comfort AB, Hamer DH.

Malar J. 2010 Jun 27;9:186. doi: 10.1186/1475-2875-9-186.

14.

Tracking abnormal cervical cancer screening: evaluation of an EMR-based intervention.

Dupuis EA, White HF, Newman D, Sobieraj JE, Gokhale M, Freund KM.

J Gen Intern Med. 2010 Jun;25(6):575-80. doi: 10.1007/s11606-010-1287-z. Epub 2010 Mar 4.

15.

Using the word 'cancer' in communication about an abnormal Pap test: finding common ground with patient-provider communication.

Simon MA, Cofta-Woerpel L, Randhawa V, John P, Makoul G, Spring B.

Patient Educ Couns. 2010 Oct;81(1):106-12. doi: 10.1016/j.pec.2009.11.022. Epub 2010 Jan 8.

16.

A theory-based approach to understanding follow-up of abnormal Pap tests.

Radecki Breitkopf C, Pearson HC.

J Health Psychol. 2009 Apr;14(3):361-71. doi: 10.1177/1359105308101674.

17.

Variations in practice guideline adherence for abnormal cervical cytology in a county healthcare system.

Singhal R, Rubenstein LV, Wang M, Lee ML, Raza A, Holschneider CH.

J Gen Intern Med. 2008 May;23(5):575-80. doi: 10.1007/s11606-008-0528-x. Epub 2008 Feb 20.

18.

The costs of an outreach intervention for low-income women with abnormal Pap smears.

Wagner TH, Engelstad LP, McPhee SJ, Pasick RJ.

Prev Chronic Dis. 2007 Jan;4(1):A11. Epub 2006 Dec 15.

19.

Development of cervical cancer control interventions for Chinese immigrants.

Jackson JC, Do H, Chitnarong K, Tu SP, Marchand A, Hislop G, Taylor V.

J Immigr Health. 2002 Jul;4(3):147-57.

20.

Interventions to improve follow-up of abnormal findings in cancer screening.

Bastani R, Yabroff KR, Myers RE, Glenn B.

Cancer. 2004 Sep 1;101(5 Suppl):1188-200. Review.

Supplemental Content

Support Center